Several familial-cancer syndromes include distinctive oral mucosal lesions.
Their genetic background involves germline mutations in tumor suppressor genes.
A multidisciplinary approach is crucial for management of the gene-carriers probands.
An early onset of oral disease may lead to genetic testing in suspected probands.
The advancements in this field lead to the development of targeted therapies.